Change to Board of Directors - Director Resignation
Released
Released
Announcement PDF
®
IMAGION BIOSYSTEMS LIMITED
(ASX: IBX)
25 March 2020
Imagion Biosystems announces change to Board of Directors
MELBOURNE — Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to
improving healthcare through the earlier detection of cancer, has accepted the resignation of non-executive
director Bronwyn Le Grice. Ms Le Grice’s resignation is effective March 31 st, 2020.
Ms. Le Grice has been a non-executive director since April of 2018 and has cited professional commitments,
including those related to her role as CEO of ANDHealth, prevent her from being able to dedicate, at this
time, the necessary time and attention appropriate for Imagion. The Company is grateful for the contributions
Ms Le Grice has made during her tenure on our Board and appreciates that the current economic and
business environment is creating both personal and business challenges for all.
-ENDS
About Imagion Biosystems
Imagion Biosystems is developing a new non-radioactive and safe diagnostic imaging technology.
Combining biotechnology and nanotechnology the Company aims to detect cancer and other diseases
earlier and with higher specificity than is currently possible. Imagion Biosystems listed on the Australian
Securities Exchange (ASX) in June 2017.
This Announcement has been approved by the Disclosure Committee of Imagion Biosystems
Limited
For further information please visit www.imagionbiosystems.com
U.S. Media Contact:
Matthew Wygant
matthew@biotechwriting.com
+1-408-905-7630
Australian Media & Investor Relations:
Kyahn Williamson, WE Communications
We-AUImagionBiosystems@we-worldwide.com
+61-3-9866-4722
Imagion Biosystems Limited
ACN 616 305 027
Level 25, 525 Collins Street, Melbourne VIC 3000
www.imagionbiosystems.com
Share your feedback
Discover